Erratum: PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section (International Journal of Cancer (2007) 120, (170-174))

Geahča maid

• PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section.
  Dahkki: Khatami, A, et al.
  Almmustuhtton: (2007)
• Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
  Dahkki: Hugosson, J, et al.
  Almmustuhtton: (2003)
• Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study.
  Dahkki: Aus, G, et al.
  Almmustuhtton: (2005)
• Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden.
  Dahkki: Hugosson, J, et al.
  Almmustuhtton: (2000)
• Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial.
  Dahkki: Aus, G, et al.
  Almmustuhtton: (2007)